A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates
Authors:
Open Access
- 5 December 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Abstract
The recent worldwide outbreaks of mpox prioritize the development of a safe and effective mRNA vaccine. The contemporary mpox virus (MPXV) exhibits changing virological and epidemiological features, notably affecting populations already vulnerable to human immunodeficiency virus (HIV). Herein, we profile the immunogenicity of AR-MPXV5, a penta-component mRNA vaccine targeting five specific proteins (M1R, E8L, A29L, A35R, and B6R) from the representative contemporary MPXV clade II strain, in both naive and simian immunodeficiency virus (SIV)-infected nonhuman primates. Immunization with two doses of AR-MPXV5 to cynomolgus macaques effectively elicits antibody responses and cellular responses. Importantly, based on the challenge model with a contemporary MPXV clade II strain, AR-MPXV5 demonstrates effective efficacy in preventing skin lesions, eliminating viremia and reducing viral loads in multiple tissues after challenge in naive male animals. More importantly, AR-MPXV5 is well-tolerated in stable chronic SIV-infected rhesus monkeys, while eliciting comparable MPXV-specific humoral and cellular responses in both naive and SIV-infected monkeys. Together, these results support further clinical development of the AR-MPXV5 vaccine.Keywords
All Related Versions
This publication has 77 references indexed in Scilit:
- Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesCell, 2024
- Cytokine storm in human monkeypox: A possible involvement of purinergic signalingCytokine, 2024
- A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus diseaseCell, 2024
- Mpox infection protects against re-challenge in rhesus macaquesCell, 2023
- Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptideCell, 2022
- A Thermostable mRNA Vaccine against COVID-19Cell, 2020
- Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsCell, 2016
- Cytokine modulation correlates with severity of monkeypox disease in humansJournal of Clinical Virology, 2014
- A survey of host range genes in poxvirus genomesInfection, Genetics and Evolution, 2013
- Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primatesVaccine, 2009